Nilandronª: an oral, once-a-day, antiandrogen for use in conjunction with orchiectomy for the treatment of metastatic prostate cancer. Similar to bicalutamide (Casodex®) and flutamide (Eulexin®), nilutamide differs from steroidal antiandrogens in that it is specific to the androgen receptor.